Creatine After Menopause: What 7 Trials and 608 Women Actually Show

For years, women over 50 asking about creatine got answers borrowed from somebody else's data: studies on college men, on athletes, on "older adults" where women were a minority of the sample and never analyzed on their own. In 2026, that finally changed. The Journal of the International Society of Sports Nutrition published the first systematic review and meta-analysis of creatine for postmenopausal women, and only postmenopausal women.¹

The research team pooled every randomized, placebo-controlled trial of creatine for postmenopausal women published since 2000: seven trials, 608 women with an average age of about 62, with interventions running from 12 weeks to a full 2 years. And the author list matters as much as the numbers. Jose Antonio, Richard Kreider, and Jeffrey Stout are three of the most cited creatine researchers alive; they helped write the field's position stands on the molecule.¹⁰ When this group sits down to grade the evidence in one population, you are reading the closest thing sports science has to a final word so far.

The verdict is refreshingly free of hype: small, real gains in lean mass and strength when creatine is paired with resistance training at 5 grams a day. Nothing at fairy-dust doses. Nothing without training. No safety signal anywhere. And one null result about bone that tells you exactly how much you can trust the rest.

Here is the whole story, translated.

Why Menopause Changes the Math on Muscle

The paper opens with the numbers that explain why this research matters. After menopause, women can lose roughly 1 percent of bone mass per year, alongside an accelerating decline in muscle strength and power.¹ Muscle mass itself erodes at about half a percent to a full percent a year. None of this announces itself. It shows up years later as the suitcase you ask for help with, the stairs you plan around, the jar you hand to someone else.

Estrogen sits underneath the whole equation. As it declines, muscle becomes less responsive to the anabolic signals that training sends, a phenomenon researchers call anabolic resistance. The review notes that postmenopausal muscle also carries lower stores of high-energy phosphate compounds, the very currency creatine helps replenish, and that women hold lower baseline creatine stores than men to begin with.^1,9 If you have read our complete guide to perimenopause, you know this is the same hormonal cascade behind so many midlife symptoms. Muscle is where it quietly does long-term damage, and because muscle and brain share a cellular energy system, the stakes are bigger than aesthetics.

So the question the meta-analysis set out to answer is genuinely important: can a cheap, thoroughly studied supplement bend that curve? The answer turns out to be yes, with conditions.

What the New Science of Creatine for Postmenopausal Women Shows

Across the seven trials, creatine beat placebo on both primary outcomes. Pooled lean mass rose by 0.37 kg (95% CI +0.05 to +0.69) more than placebo. Pooled leg-press strength rose by 7.5 kg (95% CI +2.2 to +12.8) more than placebo, with zero statistical heterogeneity, meaning the strength result pointed the same direction in essentially every trial that measured it.¹

Numbers like "+0.37 kg" sound small until you put them against the backdrop of what these years normally do. At typical postmenopausal rates of loss, that pooled gain is roughly a year or two of age-related muscle erosion handed back in a few months. The authors make the same point: even modest gains can counteract the typical loss of 0.5 to 1 percent per year, delaying the slide toward sarcopenia and frailty.¹ The wider sarcopenia evidence in adults over 50, 18 trials pooled in a 2026 review, points the same way; we cover it in creatine for sarcopenia.

The individual trials add color the pooled numbers hide. In a 12-week Brazilian trial of women averaging 65 years old, the creatine group added 36.6 kg to their leg-press one-rep max, versus 5.6 kg in the placebo group, while gaining significantly more fat-free mass.² In a 24-week trial in vulnerable older women, the creatine-plus-training group was the only group of four that meaningfully gained appendicular lean mass, up 1.31 percent while every other group drifted flat or negative.³ A 12-month trial found creatine users held onto bone at the femoral neck better than placebo, which we will come back to.⁴

The authors translate it themselves: for a typical 60-year-old woman doing resistance training, creatine is worth roughly an extra 0.3 to 0.5 kg of lean mass and 5 to 8 kg of leg-press strength versus placebo, which in practice means lifting an additional 5 to 10 pounds or squeezing out 1 to 2 more reps at a given weight.¹ Accumulated over months of training, that compounds into visibly different capability.

The Dose Finding That Should Change How You Shop

Buried in the subgroup analyses is the single most practical finding in the paper, and it is a shopping lesson as much as a science lesson.

Two of the seven trials used low doses. A 1-year trial gave women just 1 gram a day: no change in muscle, function, or body composition.⁵ A rigorous 2-year trial, the largest in the entire dataset with 200 women, used 3 grams a day without structured training: no effect on bone, lean mass, or muscle function.⁶ Every trial that showed muscle and strength gains used 5 grams a day or a weight-based equivalent.¹

The authors ran an exploratory dose analysis and found each additional gram per day tracked with roughly 0.1 kg more lean mass. Their read: about 5 grams a day appears to be the threshold where measurable gains turn on in this population, because 3 grams may maintain creatine stores without ever fully saturating muscle.¹

Now look at the supplement aisle through that lens. Creatine gummies commonly deliver 1 to 3 grams a serving. "Wellness blends" sprinkle creatine into proprietary mixes at doses they would rather you not calculate. The evidence in postmenopausal women says those doses are the ones that did nothing. If you are going to take creatine at all, the studied dose is the whole point. Our guide on how to read a supplement label shows you where to find the real number on any product.

What Creatine Did Not Do (And Why That Is Worth Trusting)

Here is the part most supplement marketing will skip, and the part that makes this paper credible.

First: creatine without exercise did nothing. In the trials with no training program, the pooled lean-mass effect was a flat zero, and strength did not budge either.¹ Swallowing creatine while living your regular life does not build muscle. The stimulus comes from training; creatine helps you train harder and recover the gains. The subgroup difference was statistically significant, which is researcher-speak for: this is the pattern, not noise.

Second: bone density did not improve. Across the trials that measured it, DXA-scanned bone mineral density showed no meaningful difference between creatine and placebo, and the authors rate that conclusion high certainty.¹ There are glimmers in the details: in the 12-month trial, women on creatine lost only 1.2 percent of femoral-neck bone density versus 2.5 percent on placebo, and their femoral shafts grew measurably wider, a geometry change linked to bending strength that standard scans can miss.⁴ A 2-year follow-up trial found similar hip-geometry improvements.⁷ But glimmers are glimmers. As of today, creatine is not a bone supplement, and anyone selling it as one is ahead of the data. What protects bone is mechanical loading: lifting, impact, progressive resistance. Creatine's contribution is helping you do more of that work.

We would rather tell you exactly what the evidence says and let the strong parts stand on their own. The same authors deposited their full dataset and analysis code in a public repository for anyone to check.¹ That is what confidence looks like in science, and it is the standard we hold our own claims to.

The Safety File Is Boring. That Is the Point.

Across all seven trials, up to 2 full years of daily use, there was not a single serious adverse event attributed to creatine.¹ One 12-month trial logged a handful of mild, short-lived GI complaints and cramps in the creatine group; every case resolved on its own and nobody dropped out over it.¹ The 2-year trials monitored kidney and liver labs throughout and found no clinically meaningful differences from placebo.

The review also addresses the creatinine confusion that sends so many women to Google in a panic after routine bloodwork. Creatinine is simply the breakdown product of creatine, so supplementing nudges the lab number up slightly. That reflects normal metabolism, not kidney damage; in these trials, kidney function measures stayed normal and matched placebo.¹ Worth knowing before your next physical, and worth telling your doctor you supplement.

And the weight question, since it stops so many women before they start: in these trials, weight changes tracked lean tissue, not fat. No study found fat gain attributable to creatine. The small early uptick some women see is water moving into muscle cells, which is where you want it; it is part of how the muscle becomes more resilient.¹ Several women in these trials read the change correctly, as muscle coming back.

The Study Nobody Has Run Yet

For all its rigor, the meta-analysis ends by pointing at a hole in the field, and it happens to be the exact window most of our readers are standing in.

Every one of the 608 women in these trials was postmenopausal, typically many years past their final period. Not one trial has ever tested creatine during the perimenopause transition itself, the years when estrogen is actively falling and muscle loss accelerates fastest. The authors flag it directly: whether starting creatine earlier could better preserve muscle while hormones fluctuate is an open question, and they call for trials in women in their late 40s.¹

So what do you do if you are 47 and not inclined to wait a decade for the trial to be run? You reason from what is known. The molecule is the same. The mechanism, restocking the cell's fastest energy currency, does not switch on at menopause. Safety is established across ages and doses. And muscle lost in the transition is harder to rebuild later, because anabolic resistance only deepens with time. Waiting for perfect data has a cost, and the cost is compounding. We walked through that logic in detail in Should Women in Menopause Take Creatine? and in our guide to creatine for women over 40.

How to Put This Study to Work This Week

The protocol that produced results in these trials is not complicated, and it does not require a gym membership contract or a shaker bottle. Distilled from the paper's own practical recommendations:¹

• Take 5 grams of creatine monohydrate, every day. Not training days only. Daily. This is the dose at which trials in postmenopausal women showed gains, and the form with all the evidence behind it.
• Skip the loading phase. The paper notes loading works but flags that older adults may have more GI sensitivity, and a steady 5 grams reaches full muscle saturation in 3 to 4 weeks anyway. Consistency beats intensity.
• Train with resistance 2 to 3 times a week, and make it progressive. The trials that worked used supervised, progressing programs: heavier weights, more reps, more sets over time. The one trial built on elastic-band work showed no creatine benefit. Bands can work; staying at the same difficulty forever does not.
• Judge it at 12 weeks, not 12 days. The shortest trial that showed results ran 12 weeks. Creatine is not a stimulant; there is nothing to feel on day 3. The changes show up in what you can lift and carry.
• Take it with a routine you already have. Compliance was above 80 percent in every trial, often above 90. That, more than any variable, is what the results were built on.

That last point is why we built Stronger the way we did: the full 5-gram dose the positive trials used, finely micronized Creavitalis® creatine in a single pre-measured sachet that dissolves in water or any drink of choice. Nothing to measure, no grit at the bottom of the glass, no reason to quit in week three, which is exactly when the biology is getting started. If you would rather add creatine on its own to a routine you already have, our micronized Creavitalis® creatine is the same German creatine at the same 5 g serving.

Questions We Hear About Creatine After Menopause